Development of new antileishmanial drugs – current knowledge and future prospects-Reference-Cited by-同舟云学术

Development of new antileishmanial drugs – current knowledge and future prospects

Published:2008-01-01 Issue:5 Volume:23 Page:708-718
ISSN:1475-6366
Container-title:Journal of Enzyme Inhibition and Medicinal Chemistry
language:en
Short-container-title:Journal of Enzyme Inhibition and Medicinal Chemistry

Author:

Le Pape Patrice¹

Affiliation:

1. Département de Parasitologie et de Mycologie Médicale, Université de Nantes, Nantes Atlantique Universités, IICiMed UPRES EA 1155, UFR de Sciences Pharmaceutiques, 1 rue Gaston VeilNantes cedex 01F-44035, France

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14756360802208137

Reference107 articles.

1. World Health Organization. The leishmaniases and Leishmania/HIV co-infections Fact sheet 116 2004.

2. Leishmaniasis

3. Leishmania and human immunodeficiency virus coinfection: the first 10 years

4. Effect of Highly Active Antiretroviral Therapy on the Incidence and Clinical Manifestations of Visceral Leishmaniasis in Human Immunodeficiency Virus--Infected Patients

5. Avaliação comparativa da eficácia e toxicidade do antimoniato de N-metil-glucamina e do Estibogluconato de Sódio BP88® no tratamento da leishmaniose cutânea localizada

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis, computational study, and antileishmanial and antifungal evaluation of phenoxyacetophenone hydrazones bearing a 4-arylthiazole moiety;Journal of Molecular Structure;2024-07

2. Single-cell ATAC sequencing identifies sleepy macrophages during reciprocity of cytokines in L. major infection;Microbiology Spectrum;2024-03-05

3. Antiparasitic drugs: a definition and scope;Advances in Antiparasitic Therapies and Drug Delivery;2024

4. Evaluation of farnesol orally and topically against experimental cutaneous leishmaniasis: In -vivo analysis;PLOS ONE;2023-08-28

5. 5‐Arylidene‐2,4‐thiazolidinediones as Cysteine Protease Inhibitors against Leishmania Donovani;ChemistrySelect;2023-08-02